Imaging Biomarkers or Biomarker Imaging?
AbstractSince biomarker imaging is traditionally understood as imaging of molecular probes, we highly recommend to avoid any confusion with the previously defined term “imaging biomarkers” and, therefore, only use “molecular probe imaging (MPI)” in that context. Molecular probes (MPs) comprise all kinds of molecules administered to an organism which inherently carry a signalling moiety. This review highlights the basic concepts and differences of molecular probe imaging using specific biomarkers. In particular, PET radiopharmaceuticals are discussed in more detail. Specific radiochemical and radiopharmacological aspects as well as some legal issues are presented. View Full-Text
Share & Cite This Article
Mitterhauser, M.; Wadsak, W. Imaging Biomarkers or Biomarker Imaging? Pharmaceuticals 2014, 7, 765-778.
Mitterhauser M, Wadsak W. Imaging Biomarkers or Biomarker Imaging? Pharmaceuticals. 2014; 7(7):765-778.Chicago/Turabian Style
Mitterhauser, Markus; Wadsak, Wolfgang. 2014. "Imaging Biomarkers or Biomarker Imaging?" Pharmaceuticals 7, no. 7: 765-778.